Firma Evotec, Autor bei PR-Web

Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

Posted on 25. January 2022 by Firma Evotec Posted in General Tagged cell, cells, drugs, evo, evotec, evotec's, ipsc, new, panomics, payment, research, royalties, securities, statements, with

– PARTNERSHIP LEVERAGES EVOTEC’S HUMAN IPSC-BASED PHENOTYPIC SCREENING AND PANOMICS PLATFORMS – AIM IS TO IDENTIFY AND VALIDATE PROMISING TARGETS AND NEW APPROACHES FOR THERAPEUTIC INTERVENTIONS Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that […]